scispace - formally typeset
B

Brent W. Zanke

Researcher at Cancer Care Ontario

Publications -  32
Citations -  2185

Brent W. Zanke is an academic researcher from Cancer Care Ontario. The author has contributed to research in topics: Colorectal cancer & Single-nucleotide polymorphism. The author has an hindex of 17, co-authored 32 publications receiving 1992 citations. Previous affiliations of Brent W. Zanke include Ottawa Hospital Research Institute & University of Ottawa.

Papers
More filters
Journal ArticleDOI

Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24

TL;DR: Using a multistage genetic association approach comprising 7,480 affected individuals and 7,779 controls, markers in chromosomal region 8q24 associated with colorectal cancer were identified and this locus has been implicated in prostate cancer.
Journal ArticleDOI

Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms.

TL;DR: It is shown that multiple SNP sites from different genes over distant parts of the genome are better at identifying breast cancer patients than any one SNP alone.
Journal Article

Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence

TL;DR: Stable expression of an activated form of MKK6 (MKK6EE), a direct activator of the stress-induced p38(HOG) mitogen-activated protein kinase pathway is sufficient for inducing features of senescence including a flattened, vacuolated, and irregular morphology, staining for acidic beta-galactosidase, and accumulation of age-associated pigments.
Journal ArticleDOI

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature.

TL;DR: A systematic review and meta-analysis conducted to test the hypothesis that oncology health care workers are at an increased risk of cancer, reproductive complications and acute toxic events identified a small incremental risk for spontaneous abortions in female staff working with cytotoxic agents.